Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
:DGX
DGX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$134.50 - $178.87
Previous CloseN/A
Volume143.08K
Average Volume (3M)1.49M
Market Cap
$19.40B
Enterprise Value$25.62B
Total Cash (Recent Filing)$315.00M
Total Debt (Recent Filing)$4.71B
Price to Earnings (P/E)22.2
Beta0.24
Next Earnings
Jul 23, 2025EPS Estimate
2.57Last Dividend Ex-Date
Apr 07, 2025Dividend Yield1.7%
Share Statistics
EPS (TTM)7.91
Shares Outstanding111,635,475
10 Day Avg. Volume1,714,715
30 Day Avg. Volume1,494,170
Financial Highlights & Ratios
PEG Ratio3.46
Price to Book (P/B)N/A
Price to Sales (P/S)1.88
Price to Cash Flow (P/CF)10.00
P/FCF Ratio9.10
Enterprise Value/Market Cap1.32
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.90
Enterprise Value/Ebitda14.15
Forecast
1Y Price Target
$185.43Price Target Upside5.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
---
Bulls Say, Bears Say
Bulls Say
EarningsQuest Diagnostics reported first-quarter results that were ahead of expectations, with significant growth in requisition volume.
Financial PerformanceQuest delivered results slightly ahead of consensus revenue and earnings estimates, showcasing investor appetite for durable and predictable growers.
Growth StrategyQuest Diagnostics' ability to continue capturing market share through hospital outreach lab acquisitions and physician lab partnerships will be key drivers of growth.
Bears Say
Macroeconomic ImpactThe 1Q weather headwind is logical and does drive estimates lower.
Market ExpectationsThere was a mild level of elevated expectations in terms of translating the previous high-single digit 3-year EPS CAGR into the new 7-9% long-term EPS CAGR.
---
Ownership Overview
0.43% Insiders
30.10% Mutual Funds
1.25% Other Institutional Investors
40.36% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DGX FAQ
What was Quest Diagnostics’s price range in the past 12 months?
Quest Diagnostics lowest stock price was $134.50 and its highest was $178.87 in the past 12 months.
What is Quest Diagnostics’s market cap?
Quest Diagnostics’s market cap is $19.40B.
When is Quest Diagnostics’s upcoming earnings report date?
Quest Diagnostics’s upcoming earnings report date is Jul 23, 2025 which is in 88 days.
How were Quest Diagnostics’s earnings last quarter?
Quest Diagnostics released its earnings results on Apr 22, 2025. The company reported $2.21 earnings per share for the quarter, beating the consensus estimate of $2.152 by $0.058.
Is Quest Diagnostics overvalued?
According to Wall Street analysts Quest Diagnostics’s price is currently Undervalued.
Does Quest Diagnostics pay dividends?
Quest Diagnostics pays a Quarterly dividend of $3.05 which represents an annual dividend yield of 1.7%. See more information on Quest Diagnostics dividends here
What is Quest Diagnostics’s EPS estimate?
Quest Diagnostics’s EPS estimate is 2.57.
How many shares outstanding does Quest Diagnostics have?
Quest Diagnostics has 111,635,475 shares outstanding.
What happened to Quest Diagnostics’s price movement after its last earnings report?
Quest Diagnostics reported an EPS of $2.21 in its last earnings report, beating expectations of $2.152. Following the earnings report the stock price went up 6.784%.
Which hedge fund is a major shareholder of Quest Diagnostics?
Currently, no hedge funds are holding shares in DGX
---
Quest Diagnostics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$185.43 (5.44% Upside)
$185.43 (5.44% Upside)
Blogger Sentiment
Bullish
DGX Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 67.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $417.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.3%
Last 30 Days ▲ 4.4%
Last 30 Days ▲ 4.4%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.45%
12-Months-Change
Fundamentals
Return on Equity
13.35%
Trailing 12-Months
Asset Growth
13.21%
Trailing 12-Months
Company Description
Quest Diagnostics
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
---
DGX Company Deck
---
DGX Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with strong revenue growth, successful partnerships, and strategic initiatives driving the business forward. However, there were some challenges, including impacts from weather, labor costs, and a strike affecting LifeLabs. Overall, the positive aspects outweighed the negatives, as evidenced by reaffirmed guidance and successful new product launches.Read More>---
DGX Revenue Breakdown
97.39% Diagnostic Information Services
2.61% All other operating segments
---
DGX Stock 12 Month Forecast
Average Price Target
$185.43
▲(5.44% Upside)
Technical Analysis
Best Analysts Covering DGX
1 Year
1 Year Success Rate
12/16 ratings generated profit
1 Year Average Return
+9.18%
reiterated a buy rating 3 days ago
Copying Eric Coldwell's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +9.18% per trade.
---